stonks4u
Sign up free
RMTI logo

RMTI Rockwell Medical, Inc.

NASDAQ Capital Market · Drug Manufacturers - Specialty & Generic · Healthcare

$7.41
-0.41 (-5.30%)

Rockwell Medical, Inc., together with its associated companies, operates as a biopharmaceutical firm specializing in treatments for chronic and end-stage kidney disease. The company provides a range of therapies and products aimed at addressing iron deficiency and supporting hemodialysis procedures, serving markets both within the United States and internationally. A key offering includes its Trif…

Market Cap: $29.25Mwww.rockwellmed.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

107
107
Aug 13Aug 13

Quote

Day Range
$7.31 – $7.57
52-Week Range
$4.89 – $21.00
Volume
$20.5K
Market Cap
$29.25M
50-Day Avg
$6.51
200-Day Avg
$8.64
Prev Close
$7.83
Open
$7.50

Valuation & Ratios

P/E Ratio
-5.56
EPS
$-1.48
P/B Ratio
0.81
P/S Ratio
0.43
Debt/Equity
0.34
Current Ratio
3.98
Dividend Yield
+0.0%
Gross Margin
+16.9%

Returns & Efficiency

Return on Equity
-14.4%
Return on Assets
-9.3%
FCF Yield
-4.0%
EV/EBITDA
-15.90

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$69.26M$-5.31M$-1.50
2024$101.49M$-480.0K$-0.25
2023$83.61M$-8.44M$-3.60
2022$72.81M$-18.68M$-18.90
2021$61.93M$-32.67M$-38.30

Social Signal Score

58
5d
58
3 mentions
—
30d
58
3 mentions
—
60d
58
3 mentions
—
90d
58
3 mentions
—
news: 3

Earnings

Wed, Nov 11(in 3 months)

Consensus estimate $-0.13 per share

2of 7 quarters beat consensus

Typical surprise -44.7% (median, so one quarter with a near-zero estimate can't distort it)

  • Thu, Aug 13$-0.34 vs $-0.23miss
  • Thu, May 7$-0.40 vs $-0.10miss
  • Thu, Mar 26$-0.10 vs $0.40miss
  • Wed, Nov 12$-0.50 vs $-0.40miss
  • Thu, Aug 14$-0.05 vs $-0.05beat
  • Mon, May 12$-0.04 vs $-0.30beat

Estimates and results for RMTI via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

RMTIhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (3)

  • Newsseekingalpha.com·2d ago·Positive

    Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call Transcript Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call Transcript

    View source ↗
  • Newszacks.com·2d ago·Negative

    Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates Rockwell Medical (RMTI) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.5 per share a year ago.

    View source ↗
  • Newsbusinesswire.com·2d ago·Positive

    Rockwell Medical Announces Second Quarter 2026 Results WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces Q2'26 results, delivering strong year-over-year growth, expanding gross margin and generating positive operating cash flow.

    View source ↗